Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Fp-025
2. Fp025
3. Fp 025
4. Fp-003
5. Fp 003
6. Fp003
7. Inhibitor Of Mmp-12 Fp-025
8. Fp-025 (c21h18n2o4s)
1. 877176-23-3
2. Fp-025
3. Fp025
4. 2iz5925nzq
5. Refchem:915169
6. Inhibitor Of Mmp-12 Fp-025
7. Fp003
8. Fp 003
9. Fp 025
10. Fp-003
11. Fp-025 (c21h18n2o4s)
12. Aderamastat (usan/inn)
13. Aderamastat [usan]
14. Orb1941603
15. Schembl1832423
16. Chembl5314499
17. Glxc-27891
18. Hy-156963
19. Cs-0905149
20. D12909
21. H39097
22. 2,4-imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-
23. 5-(3-((4-((3-methylbenzyl)oxy)phenyl)thio)furan-2-yl)imidazolidine-2,4-dione
| Molecular Weight | 394.4 g/mol |
|---|---|
| Molecular Formula | C21H18N2O4S |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 106 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 567 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
50
PharmaCompass offers a list of Aderamastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aderamastat manufacturer or Aderamastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aderamastat manufacturer or Aderamastat supplier.
A Aderamastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aderamastat, including repackagers and relabelers. The FDA regulates Aderamastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aderamastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aderamastat supplier is an individual or a company that provides Aderamastat active pharmaceutical ingredient (API) or Aderamastat finished formulations upon request. The Aderamastat suppliers may include Aderamastat API manufacturers, exporters, distributors and traders.
Aderamastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aderamastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aderamastat GMP manufacturer or Aderamastat GMP API supplier for your needs.
A Aderamastat CoA (Certificate of Analysis) is a formal document that attests to Aderamastat's compliance with Aderamastat specifications and serves as a tool for batch-level quality control.
Aderamastat CoA mostly includes findings from lab analyses of a specific batch. For each Aderamastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aderamastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Aderamastat EP), Aderamastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aderamastat USP).
